uncommonbio

Uncommon (uncommonbio.co, formerly Higher Steaks) is a Cambridge, UK biotechnology company backed by Balderton Capital. The company sold its cultivated meat platform to Vow and has pivoted to launch SymphoRNA, a new venture developing nucleic acid delivery technology for multi-RNA combination medicines that target complex diseases such as fibrosis, heart failure, and neurodegeneration. As a life-sciences research and platform company, Uncommon publishes no public developer program, API, or machine-readable API specification. This profile was added to the API Evangelist network as a portfolio lead of Balderton Capital and enriched via the local enrichment pipeline, which confirmed the absence of an API surface while capturing live domain-security posture.

uncommonbio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Nucleic Acid Delivery, and RNA Therapeutics.

🌐 Visit website 📡 Source on GitHub
4.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyLife SciencesNucleic Acid DeliveryRNA TherapeuticsBalderton Capital

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 4.1/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/uncommonbio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Uncommonbio Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: uncommonbio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/uncommonbio.png
name: uncommonbio
description: Uncommon (uncommonbio.co, formerly Higher Steaks) is a Cambridge, UK biotechnology company backed by Balderton
  Capital. The company sold its cultivated meat platform to Vow and has pivoted to launch SymphoRNA, a new venture developing
  nucleic acid delivery technology for multi-RNA combination medicines that target complex diseases such as fibrosis, heart
  failure, and neurodegeneration. As a life-sciences research and platform company, Uncommon publishes no public developer
  program, API, or machine-readable API specification. This profile was added to the API Evangelist network as a portfolio
  lead of Balderton Capital and enriched via the local enrichment pipeline, which confirmed the absence of an API surface
  while capturing live domain-security posture.
url: https://raw.githubusercontent.com/api-evangelist/uncommonbio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- balderton-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Life Sciences
- Nucleic Acid Delivery
- RNA Therapeutics
- Balderton Capital
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://uncommonbio.co/
- type: LLMsTxt
  url: llms/uncommonbio-llms.txt
- type: DomainSecurity
  url: security/uncommonbio-domain-security.yml
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 2
  pass: local-v1